Long-term outcome of idiopathic hypogonadotropic hypogonadism-Reference-Cited by-同舟云学术

Long-term outcome of idiopathic hypogonadotropic hypogonadism

Published:2012-06 Issue:3 Volume:19 Page:204-210
ISSN:1752-296X
Container-title:Current Opinion in Endocrinology, Diabetes & Obesity
language:en
Short-container-title:

Author:

King Thomas F.J.,Hayes Frances J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference22 articles.

1. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmanns syndrome): pathophysiological and genetic considerations.;Seminara;Endocr Rev,1998

2. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism.;Pitteloud;J Clin Endocrinol Metab,2002

3. Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications.;Lewkowitz-Shpuntoff;J Clin Endocrinol Metab,2012

4. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism.;Finkelstein;Ann Intern Med,1987

5. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.;Behre;J Clin Endocrinol Metab,1997

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined gonadotropin therapy to replace mini‐puberty in male infants with congenital hypogonadotropic hypogonadism;Annals of the New York Academy of Sciences;2024-06-25

2. Identification of two compound heterozygous GNRHR mutations in two siblings with congenital hypogonadotropic hypogonadism;Asian Journal of Andrology;2023-06-16

3. Hormonal therapy is effective and safe for cryptorchidism caused by idiopathic hypogonadotropic hypogonadism in adult males;Frontiers in Endocrinology;2023-01-18

4. Relations Between Body Fat Mass and Insulin Resistance in Non-Obese Patients with Idiopathic Hypogonadotropic Hypogonadism and Normal Glucose Tolerance;Hormone and Metabolic Research;2022-10

5. Monitoring of Testosterone Replacement Therapy to Optimize the Benefit-to-Risk Ratio;Endocrinology and Metabolism Clinics of North America;2022-03